A comparative study between hyperbaric ropivacaine and isobaric ropivacaine foe spinal anesthesia

A comparative study of intrathecal hyperbaric ropivacaine and isobaric ropivacaine in patients undergoing hip surgeries-A prospective randomised study - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060226

Enrollment

Registered

2023-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.5% Isobaric Ropivacaine: comparision of 15mg of 0.5% hyperbaric ropivacaine and 15mg of 0.5% isobaric ropivacaine in two group Control Intervention1: 0.5% Hyperbaric Ropivacaine: comp

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 & 2

Exclusion criteria

Exclusion criteria: Patient refusal Allergic to local anaesthetics Pregnancy Absolute contraindications for Regional anesthesia

Design outcomes

Secondary

Measure	Time frame
Secondary objective is to compare hemodynamic changes, intraoperative analgesia requirement and adverse effects in both groupsTimepoint: 5 mins 10 mins 15 mins 30 mins 1 hour 2 hours 6 hours 12 hours	—

Primary

Measure	Time frame
Primary objective is to compare onset and duration of sensory and motor blockadeTimepoint: 5 mins 10 mins 15 mins 30 mins 1 hour 2 hours 6 hours 12 hours	—

Countries

India

Contacts

Public ContactDr Sunkesula Sonia Begum

Government Medical College Kadapa

sonia.sunkesula@gmail.com8897573489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026